News

The Retimax reportedly performs innovative tests for the early screening and follow-up of important pathologies like Glaucoma, age related Maculopaty, vascular retinal degeneration and other optic nerve diseases.

Under the licensing and development agreement, Novadaq and Intuitive are working together to integrate Novadaq’s proprietary SPY imaging technology into the 3D high definition imaging capabilities of Intuitive’s

The objectives of this trial will be to assess safety, tolerability and pharmacokinetics of single and multiple ascending doses of VTX-1463 in approximately 30 healthy volunteers. The trial

According to Minnow Medical, the catheter utilizes the company’s Guided Reshaping Technology (GRT) to treat peripheral artery disease (PAD). Minnow said that its GRT treats artery disease by

Dr Newsome will oversee all aspects of HealthMine’s health education communication and information resources dedicated to raising awareness of subclinical zinc deficiency and the risks of chronic copper

The new company will focus on the discovery and development of proprietary small molecule drugs for acute and chronic neurological conditions where the mechanism of defective energy metabolism

Teva Pharmaceutical Industries, a generic pharmaceutical company, has received the FDA approval for the company’s abbreviated new drug application to market its generic version for Bayer Healthcare Pharmaceuticals’s

The analysis compared the growth rate of geographic atrophy (GA) lesions, as measured by retinal photography, in patients treated with daily doses of placebo or 100mg or 300mg

and to help ensure that NIH-funded research in this area is ethically responsible, scientifically worthy, and conducted in accordance with applicable law. Internal NIH procedures, consistent with Executive